Avigen, Inc. Announces Year-End 2007 Earnings Conference Call
January 30 2008 - 8:00AM
Business Wire
Avigen, Inc. (Nasdaq:AVGN), a biopharmaceutical company innovating
therapeutics for neurological care, will hold its quarterly
conference call to discuss year-end results on Wednesday, February
6, 2008, at 1:00 p.m. ET (10:00 a.m. PT). Kenneth Chahine, Chief
Executive Officer, and Michael Coffee, Chief Business Officer, can
be heard by calling 888-713-4205 (U.S.) or 617-213-4862 (non-U.S.
locations) using passcode 16083697. This call is being webcast by
Thomson/CCBN and can be accessed at Avigen�s website at
www.avigen.com. The webcast is also being distributed through the
Thomson StreetEvents Network. Individual investors can listen to
the call at www.earnings.com, Thomson�s individual investor portal,
powered by StreetEvents. Institutional investors can access the
call via Thomson StreetEvents (www.streetevents.com), a
password-protected event management site. A rebroadcast of the call
will be available shortly after the conclusion of the session. The
replay may be accessed over the Internet at www.avigen.com or by
calling 888-286-8010 (U.S.) or 617-801-6888 (non-U.S. locations)
using passcode 57208063. About Avigen Avigen, Inc. is a
biopharmaceutical company focused on unique small molecule
therapeutics and biologics to treat serious, chronic neurological
disorders, including neuropathic pain and neuromuscular spasm and
spasticity. For press releases and other corporate information,
visit our website at www.avigen.com.
Avigen (MM) (NASDAQ:AVGN)
Historical Stock Chart
From Jun 2024 to Jul 2024
Avigen (MM) (NASDAQ:AVGN)
Historical Stock Chart
From Jul 2023 to Jul 2024